Completed PHASE1 INTERVENTIONAL 1-arm NCT00680667

Clinical Trial of Trametes Versicolor in Women With Breast Cancer

Phase I Clinical Trial of Trametes Versicolor in Women With Breast Cancer

Sponsor: Masonic Cancer Center, University of Minnesota

Interventions Coriolus versicolor extract

Updated 6 times since 2017 Last updated: Nov 27, 2017 Started: Apr 30, 2007 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Breast Cancer and is currently completed. Masonic Cancer Center, University of Minnesota leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Masonic Cancer Center, University of Minnesota
National Center for Complementary and Integrative Health (NCCIH)

Data source: Masonic Cancer Center, University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kenmore, United States
• Minneapolis, United States